CHARACTERISTICS OF IncP-1 PLASMIDS
==================================

A characteristic feature of all plasmids, including IncP-1 plasmids, is that they belong to specific incompatibility (Inc) groups. Plasmids are classified into Inc groups based on their replication and partitioning systems: two plasmids belonging to the same Inc group are unable to coexist in a single bacterial cell ([@B44]).

Members of the *Enterobacteriaceae* family and the genus *Pseudomonas* carry plasmids belonging to more than 30 Inc groups. Plasmids from four of these groups (IncP, W, N, and Q) can transfer between and maintain themselves in both enteric bacteria and strains of *Pseudomonas*([@B16]). In particular, IncP plasmids are widely distributed in Gram-negative bacteria, e.g., in *Escherichia coli*, *Pseudomonas*spp., *Klebsiella aerogenes*, and *Sphingomonas* ([@B56]; [@B43]). It should be added that IncP-1 in the *Pseudomonas* plasmid classification corresponds to IncP in the *E. coli* plasmid classification ([@B57]).

The plasmids of the subgroup IncP-1 are of considerable interest to both molecular biologists and environmentalists due to their highly efficient conjugative transfer and ability to replicate in a broad range of hosts ([@B43]). These plasmids demonstrate great diversity -- a phylogenetic study has shown the presence of 45 backbone genes on IncP-1 plasmids, but only 33 are shared by all the plasmids that have been completely sequenced to date.

A detailed phylogenetic analysis and study of the amino acid sequence of protein TrfA, which initiates plasmid replication, have allowed the classification of group IncP-1 into six subgroups: -α, -β, -γ, -ε, -δ ([@B10]), and -ζ ([@B29]) and also into an unnamed subgroup ([@B30]). Unpublished data also indicate the existence of a η subgroup ([@B39]). IncP-1 plasmids have been identified in clinical and environmental, phylogenetically very distant, host bacterial species from around the world. Bacteria carrying these plasmids have been isolated from soil in areas contaminated by industry, pig manure, wastewater of industrial origin, river sediment, and fresh water ([@B10]; [@B29]; [@B39]). Comparative analysis of the nucleotide sequences of plasmids belonging to the IncP-1 subgroups α and β demonstrated the high similarity of their gene organization and also led to the identification of adaptive genes called "load genes." The backbone sequences of these plasmids are responsible for the regulation of replication, stable maintenance in a bacterial cell and efficient conjugative transfer. In plasmids of the IncP-1β subgroup, the Tra1 and Tra2 regions of the backbone, that mediate conjugative transfer, are always separated by regions of clustered restriction sites, which may represent hotspots for the integration of various determinants. These regions can be a site for the insertion of mobile genetic elements (MGE) carrying catabolic genes, and antibiotic and heavy metal resistance determinants. The capacity for MGE integration is highly variable among IncP-1 plasmids. Plasmids pJP4, pSS60, and pSS50, belonging to the subgroup IncP-1β, contain one site for the integration of catabolic genes in their plasmid backbone, which is located between the *oriV*and *trfA* system replication sequences. The number of insertions in the backbone varies among IncP-1 plasmids ([@B61]). pB4 is the only plasmid known to have three insertion sites: catabolic genes grouped into an operon are located near the *oriV* sequence, and antibiotic resistance determinants are located at both ends of region Tra2 ([@B1]).

There are currently only three known representatives of the subgroup IncP-1δ, namely plasmids pEST4011, pIJB1, and pAKD4. Plasmid pAKD4 is regarded as the prototype of this subgroup because it is the only one to possess the complete backbone sequence. Like other IncP-1 plasmids, those of subgroup δ carry specific genes that are located on transposons integrated within the plasmid backbone ([@B41], 2012).

More than 50 plasmids belonging to the subgroup IncP-1ε have recently been identified and characterized. These plasmids confer resistance to a broad spectrum of antibiotics. This is due to the presence of a class 1 integron that carries the gene *sul1* responsible for sulphonamide resistance at its 5 ′ end, plus gene cassettes carrying several determinants of resistance to other antibiotics ([@B21]). Plasmids belonging to subgroup IncP-1ε exhibit great diversity ([@B40]).

ANTIBIOTIC RESISTANCE GENES PRESENT ON IncP PLASMIDS
====================================================

The extensive use of antibiotics for the treatment of humans and animals, and to stimulate the growth of livestock, has led to the rapid emergence and spread of resistance determinants to a broad spectrum of antibiotic substances ([@B3]; [@B6]; [@B33], [@B34]; [@B53]). These determinants are located mainly on MGE such as plasmids and conjugative transposons, which ensures their spread by horizontal gene transfer. Horizontal gene transfer involving the acquisition of foreign DNA by transduction, transformation, or conjugation, is quite common among bacteria and plasmids play a key role in this process ([@B7]; [@B27]; [@B49]). Among the plasmids conferring resistance to antibiotics, representatives of the incompatibility groups P, Q, N, and W have been identified. These are characterized by their wide host range, including pathogenic bacteria, and so pose a serious threat to human health ([@B16]). Numerous studies have demonstrated that the prevalence of such plasmids in different environments is very high, e.g., in soil, surface waters, wastewaters, and natural fertilizers ([@B17]; [@B18]; [@B13]; [@B40]; [@B21]).

There are four basic mechanisms of plasmid-encoded antibiotic resistance: (i) enzymatic hydrolysis of the antibiotic molecule, which results in inactivation of the compound, (ii) enzymatic modification of the antibiotic to prevent interaction with the cellular target, (iii) efflux, which removes the antibiotic from the interior of the cell via specific cell membrane pumps, and (iv) a reaction called "bypass," which is the formation of an alternative metabolic pathway that allows bypassing of the blocked stage and modification of the antibiotic target ([@B2]). The genes encoding the proteins responsible for these mechanisms are found on plasmids present in both clinical and environmental bacterial isolates ([@B8]; [@B3]; [@B66]).

**Table [1](#T1){ref-type="table"}** shows plasmids from IncP-1 group, well characterized in terms of phenotype and molecular mechanisms of observed resistance to antibiotics and heavy metals. Resistance plasmids classified within subgroup IncP-1α were first identified in hospital isolates of *Pseudomonas aeruginosa* and *K. aerogenes*. These were found to encode multi-drug resistance (MDR) against antibiotics including penicillin, kanamycin, and tetracycline ([@B1]). Using the exogenous plasmid isolation method [@B16] found resistance plasmids, including those belonging to the subgroup IncP-1α, in bacterial communities from activated sludge derived from wastewater treatment plant (WWTP). Twelve plasmids were identified carrying an antibiotic and heavy metal resistance determinant, and ten of these could be classified to group IncP. These studies confirmed the wide distribution of this Inc group in these environments.

###### 

General features of IncP-1 plasmids carrying resistance genes.

  Plasmid                                  Size (kb)       IncP-1 subgroup   Resistances                                                                   Resistance genes                                             Detected transposons                                                              Reference/accession No.
  ---------------------------------------- --------------- ----------------- ----------------------------------------------------------------------------- ------------------------------------------------------------ --------------------------------------------------------------------------------- ----------------------------
  pAKD1                                    58,246          IncP-1β           Sp, Sm, Su, Hg                                                                *aadA, sul1, merE*                                           Tn*21*-like transposon                                                            [@B40]/JN106164.1
  pB2/pB3^[\#](#fnT1f01){ref-type="fn"}^   60,732/56,167   IncP-1β           Aminoglycosides, β-lactam, Cm, Su, Tc, quaternary ammonium compounds          *aadA2, bla*~NPS_2~, cmlA1, sul1, tetA(C), tetR(C), qacE∆1   Tn-*tet,*Tn*402*                                                                  [@B22]/NC_006388.1
  pB4                                      79,370          IncP-1β           β-lactam, tripartite multi-drug resistance (MDR) efflux system, Sm, Em, Chr   *bla~NPS_1~*, strAB, mexCD-oprJ, chr                         Tn*5393c*, Tn*5719*                                                               [@B16], [@B52]/NC_003430.1
  pB5                                      64,696          IncP-1α           Sm, Tc, Km, Gm, Su, quaternary ammonium compounds                             *aacA4, aacC1, tetA, tetR, aphA, sul1, qacE∆1*               nd                                                                                [@B16]; [@B50]/NC_019020.1
  pB6                                      58              IncP-1β           Tc, Sm, Sp, Cm, Su                                                            nd                                                           nd                                                                                [@B16]
  pB8                                      57,198          IncP-1β           Sm, Sp, β-lactam, Su, quaternary ammonium compounds                           *aadA4, oxa2, sul1, qacE∆1, qacF*                            Tn*5501,*"cryptic" Tn, Tn*402/*Tn*5090*,Tn*QAC*/(Tn*3* family)*,*Tn*501*/Tn*21*   [@B36]/NC_007502.1
  pB10                                     64,508          IncP-1β           β-lactam, Su, Sm, Tc, quaternary ammonium compounds, Hg                       *oxa2, sul1, strAB, tetA, qacE∆1, mer*                       Tn*5393c*, Tn*1721,*Tn*501*                                                       [@B35]/NC_004840.1
  pB11                                     66,911          IncP-1α           Tc, Ap, Km, Hg                                                                *tetA, tetR, aphA, merE*                                     Tn*501,* Tn*5053*                                                                 [@B16], [@B50]/CP002152.1
  pB12                                     64,393          IncP-1β           Tc, Sm, Sp, Em, β-lactam / Su, quaternary ammonium compounds                  *tetA, aacA4, oxa2, sul1, qacE∆1*                            Tn*21*, Tn*402*                                                                   [@B16], [@B39]/JX469826.1
  pTB11                                    68,869          IncP-1α           Aminoglycosides, β-lactam, Tc                                                 *aphA, aadA1, aacA4, oxa2, tetA, tetR*                       Tn*402/*(Tn*5090*), Tn*1721,*                                                     [@B55]/NC_006352.1
  pMCBF1                                   62,689          IncP-1ζ           Multi-drug efflux (MDE) outer membrane prot. NodT family, Hg                  *oprN, merE*                                                 Tn*5053*                                                                          [@B29]/AY950444.1
  RP4/RK2                                  60,099          IncP-1α           Tc, Km, Ap                                                                    *tetA, aph*                                                  Tn*4371*, Tn*1*                                                                   [@B32]/L27758.1
  pTH10                                    70              IncP-1α           Tc, Km, Ap                                                                    nd                                                           nd                                                                                [@B20]
  R751                                     53,423          IncP-1β           Tp                                                                            *dhfrIIc*                                                    Tn*402/*Tn*5090*, Tn*501*                                                         [@B58]
  pKJK5                                    54,383          IncP-1ε           Tc, Tp, aminoglycosides, Su, Sp, quaternary ammonium compounds                *tetA, tetR, dfrA1, aadA11b, sul1, qacE∆1*                   Tn*402*                                                                           [@B11]/NC_008272.1
  pG527                                    80,762          IncP-1α           Aminoglycosides, Km, Sm, β-lactam, Tc                                         *aadA1, aphA, sph,*bla ~*TEM-67*~, tetA, tetR                Tn*3*, Tn*7*, Tn*1721*                                                            [@B39]/JX469830.1
  pSP21                                    72,683          IncP-1α           Tc, Km, aminoglycosides, β-lactam                                             *tetA, tetR, aph, aadA1, aacA4, oxa2*                        Tn*402*                                                                           [@B32],[@B50]/NC_019021.1
  pBS228                                   89,147          IncP-1α           Aminoglycosides, Sp, Tp, Tc, β-lactam, Hg                                     *aadA, dhfr, tetA,*bla*~TEM-67~*, aph, merE                  Tn*1013*, Tn*5718*, Tn*1*, Tn*7*                                                  [@B19]/NC_008357.1
  BRA100                                   56,265          IncP-1β           Aminoglycosides, Su, quaternary ammonium compounds, Hg                        *aacA4, strAB, sul1, qacE∆1, merE*                           Tn*6305*/(Tn*3* family)                                                           Unpublished/CP003505
  pWEC911                                  74,056          IncP-1            Tc,*β*-lactam, Km, Hg                                                         *tetA,*bla~*TEM-67*~, aphA, merE                             nd                                                                                [@B39]/JX469833.1
  pKSP212                                  54,342          IncP-1            Aminoglycosides, Su*, Hg*                                                     *aac(6)-Ib, sul1, merE*                                      Tn*3*                                                                             [@B39]/JX469831.1
  pBRSB222                                 36,880          IncP-1            Aminoglycosides, β-lactam, Su, quaternary ammonium compounds                  *aadA5, oxa2, sul1, qacE*∆*1*                                nd                                                                                [@B39]JX469825.1
  pKS208                                   50,604          IncP-1            Aminoglycosides, Km, β-lactam                                                 *aac(6)-Ib, aphA1, pEC-IMPQ_139*                             Tn*1525*, Tn*5053*/Tn*402*                                                        [@B39]/JQ432564.1

Ap, ampicillin; Cb, carbenicillin; Cm, chloramphenicol; Gm, gentamicin; Km, kanamycin; Nx, nalidixic acid; Sm, streptomycin; Sp, spectinomycin; Su, sulfanilamide; Tc, tetracycline; Tp, trimethoprim; Tm, tobramycin; Hg, inorganic mercury; nd, not determined.

*Plasmids pB2 and pB3 differ only by a duplication of a tetA(C)-tetR-tnpAIS26 fragment in pB2*.

To date, the complete nucleotide sequences of six resistance plasmids belonging to subgroup IncP-1α have been determined. These plasmids, RP4/RK2, pTB11, pBS228, pB5, pB11, and pSP21, show a high degree of similarity with respect to elements of their plasmid backbone, while they are distinguished by the nature of the genes located within their adaptive modules (e.g., ISTB11, ISSP21, Tn*402* derivatives, Tn*1*, Tn*7*). Plasmid pB5 contains an integron of class 1 carrying a resistance cassette with *aac*C1 and *aacA4*genes, which encode enzymes that provide resistance to kanamycin, gentamicin, and tobramycin ([@B50]). The IncP-1α plasmids contain different variants of the integron *aadA* gene cassette (*aadA1*, *aadA2*, *aadA4*, and *aadA5*), which encode streptomycin/spectinomycin-300-*O*-adenylyltransferases conferring resistance to the aminoglycosides streptomycin and spectinomycin ([@B54], [@B55]). The *aadA2* gene cassette is widely distributed, having been identified in the integrons of many bacteria belonging to at least 11 genera. Numerous studies have demonstrated that different environmental and pathogenic bacteria share a common pool of integron-specific resistance gene cassettes ([@B54], [@B55]).

In the case of plasmids pTB11 and pSP21, a class 1 integron carrying genes that determine bacterial resistance to aminoglycosides is located within transposon Tn*402*. In addition, these plasmids possess a region containing genes for tetracycline resistance (*tetA* and *tetR*; [@B55]; [@B50]).

The IncP-1α plasmid pTB11 carries the *aphA-orf3* module, encoding aminoglycoside-30-phosphotransferase responsible for aminoglycoside resistance, that shares the highest degree of similarity with the corresponding gene of plasmid RP4, originating from a clinical isolate. Another aminoglycoside resistance gene cassette located on pTB11 and pSp32 encodes an aminoglycoside-60-*N*-acetyltransferase mediating resistance to different aminoglycosides such as tobramycin, amikacin, and gentamicin. Two other aminoglycoside resistance gene cassettes, *aadB* and *aacA29b*, which respectively, code for an aminoglycoside-200-*O*-adenylyltransferase and an aminoglycoside-60-*N*-acetyltransferase, have also been identified on IncP-1α plasmids. The *aadB* gene was found on a plasmid from a clinical isolate of *Acinetobacter baumannii*, while an *aacA29b* gene cassette, present on a plasmid, represents a new variant of *aacA29a* previously found on In59 in a clinical *P. aeruginosa* isolate ([@B45]).

Resistance plasmids are also represented in subgroup IncP-1β. These include the fully sequenced plasmids pB2/pB3, PB4, PB8, and PB10. These plasmids carry a class 1 integron or, in the case of PB4, a fragment of Tn*402*. Besides *sul1* that confers resistance to sulfonamides, these plasmids may also contain genes for resistance to other antibiotics and chemotherapeutics, e.g., *oxa* (PB8, PB10, and pB11) and *bla* (PB4 and PB3), encoding β-lactamase enzymes responsible for resistance to β-lactam antibiotics. Parts of the *oxa1* gene cassette in plasmid pSp33 and *blaNPS1* on the Tn*402* remnant in this plasmid are nearly identical to corresponding regions identified in different Korean clinical isolates of *Salmonella enterica* ssp. *enterica* ([@B25], [@B26]) and *P. aeruginosa* ([@B23]; [@B31]), respectively. However, some *bla* genes identified in this subgroup of plasmids have novel sequences. All of the aforementioned IncP-1β plasmids also carry genes encoding resistance to streptomycin, a member of the aminoglycoside antibiotic family. Plasmids PB4 and PB10 contain transposon Tn*5393c*, which includes the genes *strA* and *strB,* encoding aminoglycoside-3*′′*-*O*-phosphotransferase and aminoglycoside-6-*O*-phosphotransferase, respectively, that modify the streptomycin molecule, thus causing its inactivation. Identical or almost identical copies of Tn*5393* were recently identified in different human, fish, and plant pathogens. Plasmid pB10 also possesses the tetracycline resistance transposon Tn*1721*, that was first described in *E. coli* ([@B4]). A very similar transposon has been found in conjugative plasmids from the fish pathogen *Aeromonas salmonicida* ([@B47]), the human pathogen *Salmonella enterica* ssp. *enterica* ([@B15]) and a clinical isolate of *E. coli* ([@B14]). With the use of plasmid pB10, carrying amoxicillin, streptomycin, sulfonamide, and tetracycline resistance genes, is has been shown that this broad-host-range IncP-1 plasmid can be transferred to foodborne pathogens (*Salmonella* spp. and *E. coli* O157:H7) under laboratory conditions ([@B63]). These results show that the antibiotic resistance genes encoded on plasmid pB10 can be expressed in the new hosts (pathogenic organisms) making these pathogens resistant to multiple antibiotics. These studies have shown that there is a serious risk to human health in cases of such transfer. The plasmid PB3 carries the gene *clmA1*conferring resistance to chloramphenicol. The product of the *clmA1* gene is a protein that acts as an efflux pump, which removes the drug from the bacterial cell ([@B37]). The genetic modules on these IncP-1β plasmids consist mainly of MGE that carry diverse determinants conferring resistance to different aminoglycosides, β-lactams, macrolides, sulphonamides, tetracycline, trimethoprim, disinfectants, and mercury ions. The greatest MGE diversity has been observed in plasmids of this subgroup isolated from bacteria living in WWTP ([@B51]). WWTP bacteria represent a reservoir for β-lactamase genes that have yet to be isolated from clinical strains. Mobile integron gene cassettes seem to function in the dissemination of β-lactamase genes in sewage habitats.

An important role in the spread of resistance genes in agricultural systems is played by representatives of subgroup IncP-1ε. The study of [@B21] showed that fifty plasmids belonging to this subgroup, isolated from samples of soil and manure, contain integrons of class 1 with gene cassettes plus the gene*sul1*(sulphonamide resistance). The nucleotide sequences of four of these plasmids have been determined (pKS77, pHH3414, pHH128, and pHH3408) and they differ mainly in the organization of the elements in transposon Tn*402*. These elements are a class 1 integron IS1326 and, in the case of plasmids pHH3414, pKS77, and pHH128, transposon Tn*1721* carrying the tetracycline resistance genes *tetA* and *tetR*. The resistance integrons contain the gene cassettes *aadA,* (pHH3414), *aadB* (pKS77), *aadA1b*, *dfrA1b*, and two copies of *catB* (pHH128; [@B21]). The different *aad* gene variants encode adenyltransferases that modify the streptomycin and spectinomycin molecules, resulting in their inactivation. A similar mechanism is employed by the chloramphenicol acetyltransferase encoded by the *cat* genes to confer resistance to chloramphenicol. The *dfr* gene permits bacterial cells to survive in an environment with high concentrations of trimethoprim ([@B37]).

Interestingly, many studies have demonstrated a close relationship between the occurrence of MDR and resistance/tolerance to heavy metal ions ([@B24]). Bacterial strains isolated from agricultural soil receiving wastewater can exhibit high levels of both metal and antibiotic resistance. [@B42] isolated 64 bacteria belonging to the genera *Pseudomonas*, *Azotobacter*, and *Rhizobium* from wastewater-irrigated soil. All the *Pseudomonas* isolates were resistant to heavy metals and cloxacillin, and more than half were also resistant to methicillin. Among these strains were MDR isolates. [@B9] found that 40 strains isolated from agricultural soils irrigated with wastewater showed resistance to most of the tested heavy metals (Ni, Cu, Zn, Pb). Moreover, around 75% of these strains were resistant to tetracycline, 57.5% to doxycycline, and 50% to ampicillin and nalidixic acid. The plasmids isolated from these resistant strains all belonged to the IncP group. Out of 12 pAKD plasmids (IncP-1 group) isolated from Norwegian soils only one, pAKD1, encoded antibiotic resistance in addition to mercury resistance. This plasmid carries a MDR Tn*21*-like transposon with a class 1 integron ([@B40]). These data suggest heavy metals treatment might have co-selected for MDR genes. This is consistent with previous and present observations that pollution with heavy metals can cause a rise in the abundance of drug resistance genes ([@B12]; [@B38]).

CONCLUSION
==========

The increasing use of antibiotics in human and veterinary medicine and agricultural production systems has caused the increasing development of high levels of and novel antibiotic resistances and the rapid global spread of antibiotic resistance genes ([@B5], [@B6]; [@B27]; [@B37]; [@B40]). A consequence of the horizontal transfer of the genes located on MGE, especially on Broad-host-range plasmids is the rising detection and levels of resistant bacteria, particularly of MDR bacteria, both in clinical and natural environments ([@B16]; [@B8]).

IncP-1 plasmids are characterized by their wide distribution in the environment and ability to efficiently replicate in the cells of diverse hosts. In addition, the presence of transposons carrying both antibiotic and heavy metal resistance genes on these plasmids permits the host bacteria to survive and multiply in environments contaminated with these compounds. The broad-host-range IncP-1 plasmids carry determinants for resistance to at least one heavy metal (Ni, Cd, Co, Cu, Hg, Pb, Zn), and antibiotics of different groups, i.e., tetracyclines, quinolones, aminoglycosides, sulfonamides, β-lactams, and chemotherapeutics. This fact is not surprising in light of recent data showing that heavy metals present in the environment might have co-selected for MDR genes ([@B38]). The two main mechanisms of antibiotic resistance encoded on IncP-1 plasmids are mediated by efflux pumps and enzymatic modification or hydrolysis of the antibiotic molecule. IncP-1 plasmid-containing bacteria are also key players in the horizontal transfer of antibiotic resistance in agricultural systems. It has been suggested that the spread of multi-resistant bacteria in soil, water, and WWTPs is mainly due to their possession of IncP-1 plasmids ([@B35], [@B36]; [@B11]; [@B9]; [@B29]; [@B40]).

Based on their DNA sequences, it can be concluded that the vast majority of these resistance genes are located on MGE such as transposons and/or integrons (Tn*402*-like transposon with a class 1 integron), embedded within these transposons. In addition, the presence of different combinations of MGE and integrons in IncP plasmids as well as of characteristic hot spots for the integration of accessory elements creates unlimited possibilities for rearrangements of the genetic material of these plasmids. It therefore appears that the spread of resistance genes would be possible and quite hazardous in infection control. Literature data show that many representatives of this group of plasmids carrying resistance genes have been identified in pathogenic bacteria of the genus *Escherichia*, *Salmonella*, *Shigella*, *Klebsiella*,*Aeromonas*, and *Pseudomonas*. Of course, in order to determine the level of risk of the spread of resistance genes located on these plasmids extensive experimental studies are required. However, the demonstrated ability to transfer multiresistance pB10 plasmid, isolated from a WWTP, to the foodborne pathogens *Salmonella* spp. or *E. coli* O157: H7 with expression of most of the transferred resistance genes in these strains poses a real threat to the life and health of people ([@B63]).

Detailed analysis of IncP-1 plasmid genomes can shed light on the adaptive mechanisms underlying bacterial evolution and this information may be used to develop effective methods of bioremediation of contaminated land with xenobiotic and antibiotics and heavy metals. Intensive research on the biodegradation of compounds that are a serious threat to the environment has led to the isolation and characterization of bacterial strains that can use these substances as a source of carbon and energy. In many cases, the adaptation of these microorganisms is due to plasmids (mainly of Inc group P) that carry genes encoding enzymes involved in the degradation of xenobiotics. It is known, that the degradative plasmids (IncP-1, P-7, and P-9) contain catabolic genes, often arranged as operons, encoding enzymes required for the degradation and utilization of many toxic compounds including naphthalene, toluene, chlorobenzene, p-toluenesulfonate, 2,4-D, haloacetate, and atrazine ([@B65]; [@B43],[@B44]). The majority of bacterial genes encoding enzymes of catabolic pathways are located on MGE such as plasmids, insertion sequences (e.g., as a form of composite transposons), transposons, integrons, genomic islands, and phage genomes ([@B59]; [@B60]; [@B28]; [@B48]).

Theoretically, genetic modules present in this type of element (both in catabolic and resistance plasmids) may be used in the construction of genetically modified strains that are optimized for use in bioremediation and biotechnology ([@B64]; [@B62]; [@B46]). This is of great importance due to the fact that these antimicrobial agents are powerful inhibitors of xenobiotic biodegradation activities, mainly due to their bacteriostatic or bactericidal activities. However, before the broader implementation of such microorganisms, further research is required to thoroughly characterize them in order to limit the spread of antibiotic resistance genes.
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